HealthEquity

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

HQY reports strong Q1 performance, faces challenges in seasonality and yield expectations

HQY's Q1 performance reflects strong growth and positive financial results, driven by increased HSA adoption and employer interest. However, the company faces challenges related to seasonality and yield expectations. To capitalize on opportunities, HQY should focus on reaching its enhanced rates target and addressing service fee pressures.

HealthEquity reports robust Q2 performance and eyes market expansion

HealthEquity's strong Q2 performance, driven by revenue and EBITDA growth, is supported by the enhanced rates product and expanded network partner footprint. While facing short-term challenges in interchange revenue and M&A environment changes, the company is well-positioned to capitalize on opportunities presented by market dynamics and regulatory discussions.

HealthEquity reports robust Q3 performance and optimistic fiscal '25 outlook

HealthEquity's Q3 performance showcased strong financial results, with raised fiscal '24 guidance and optimistic initial fiscal '25 guidance. The company is well-positioned to navigate challenges and capitalize on opportunities, particularly in expanding its market presence and enhancing customer satisfaction.

HealthEquity (HQY) posts record earnings, eyes growth through innovation

HealthEquity (HQY) delivered strong financial results, exceeding expectations and demonstrating growth across key metrics.
While facing challenges in certain business segments, the company's focus on technology, customer experience, and long-term quality positions it well for the future.
Opportunities for R&D acceleration, innovation through M&A, and expansion of product offerings present avenues for sustained growth and competitive advantage.

HealthEquity reports robust Q1 results, raises fiscal '24 guidance

HealthEquity's Q1 performance reflects strong financial growth and stability, with revenue, EBITDA, and HSA metrics showing positive trends.
The company's proactive approach to guidance revision, service fee optimization, and strategic partnerships positions it well for future success.
Challenges in managing fee pressures, COBRA impact, and M&A environment slowdown require focused strategies for sustained growth and market leadership.

HealthEquity reports robust Q2 results, eyes growth amid market shifts

HealthEquity's Q2 results reflect strong financial performance and strategic positioning for future growth.
Despite challenges in revenue consistency and market dynamics, the company's strengths in service quality and market leadership are key assets.
Opportunities in revenue growth, legislative changes, and market demand provide avenues for HealthEquity's continued success.

HealthEquity reports strong Q3 growth and bullish outlook for fiscal '25

HealthEquity's Q3 2024 earnings call highlighted impressive financial performance, strategic acquisitions, and optimistic guidance for fiscal '25, underlining the company's growth trajectory and market positioning.
While facing challenges in integrating acquisitions, maintaining competitive pricing, and managing asset maturation, HealthEquity remains focused on growth opportunities through enhanced yield products and consumer empowerment.
The company's emphasis on stability, profitability, and reinvestments, coupled with a proactive approach to engaging investors, sets the stage for continued success and market differentiation in the evolving healthcare landscape.

HealthEquity reports robust Q4 earnings, eyes growth through innovation

HealthEquity delivered strong financial results in Q4 2024, showcasing robust revenue growth and operational performance.
The company's focus on enhancing shareholder value, strategic mergers, and technology investments positions it well for future growth.
Challenges in pricing pressures and technology spend trends require careful navigation, while opportunities in HSA cash rates and digital innovations offer avenues for expansion.
Overall, HealthEquity's performance highlights resilience, strategic foresight, and a commitment to driving long-term value for stakeholders.

HealthEquity reports robust Q1 results, eyes cost savings and growth

HealthEquity's Q1 performance reflects strong growth in revenue, EBITDA, and HSA assets, underlining its market strength and operational efficiency.
The company's focus on cost savings, customer experience enhancement, and new sales growth positions it well for future success and market expansion.
While facing challenges in transitioning processes and managing costs, HealthEquity is leveraging opportunities in technology and market expansion to drive continued growth.

HealthEquity reports robust Q2 growth, unveils innovative healthcare payment options

HealthEquity's Q2 performance reflects strong growth and strategic initiatives to enhance healthcare payment options.
While facing challenges in margins and market conditions, the company's focus on innovation and team efforts bode well for future success.
Opportunities lie in leveraging HPAs, digital integration, and market expansion to drive continued growth and customer value.
Overall, HealthEquity's performance and outlook demonstrate resilience and a commitment to driving healthcare financial solutions.

HealthEquity reports robust Q3 growth amidst challenges and opportunities

HealthEquity's Q3 performance reflects strong growth and market positioning, despite challenges in gross profit margins.
The company's focus on legislative support, technology utilization, and diversified revenue streams positions it well for future expansion.
Opportunities in expanding the TAM, enhancing service delivery, and leveraging commuter offerings indicate a promising outlook for HealthEquity.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

HealthEquity continues to present highly attractive fundamentals. FY'25 is guidance raised to ~$1.18Bn in revenue and ~$3.10/share in earnings. Technicals are robust on longer-term time frames, with price structure strengthening after demand-fill at ~$55-$60s.

HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy

Learn how to use a Health Savings Account (HSA) to keep more money in your paycheck and build future savings Learn how to use a Health Savings Account (HSA) to keep more money in your paycheck and build future savings

HSA Week 2024 Offers Free Resources and Personalized Healthcare Savings Paths

NEW YORK, NY / ACCESSWIRE / August 14, 2024 / HealthEquity, Inc. ("HealthEquity") has disclosed a data breach affecting the personal information of its customers. The breach compromised sensitive personal information entrusted to HealthEquity.

INVESTIGATION ALERT: Levi & Korsinsky, LLP Investigates HealthEquity, Inc. (NASDAQ: HQY) Data Breach

DRAPER, Utah, Aug. 13, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced plans to release its second quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Tuesday, September 3, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, September 3, 2024, at 4:30 p.m. Eastern Time during which management will review the Company's second quarter results.

HealthEquity Sets Date to Announce Second Quarter Results Presentation at Conferences

NEW YORK, NY / ACCESSWIRE / August 13, 2024 / HealthEquity, Inc. ("HealthEquity") has disclosed a data breach affecting the personal information of its customers. The breach compromised sensitive personal information entrusted to HealthEquity.

HealthEquity, Inc. (NASDAQ: HQY) Data Breach - Levi & Korsinsky, LLP Announces an Investigation

NEW YORK, NY / ACCESSWIRE / August 12, 2024 / HealthEquity, Inc. ("HealthEquity") has disclosed a data breach affecting the personal information of its customers. The breach compromised sensitive personal information entrusted to HealthEquity.

ATA BREACH: HealthEquity, Inc. (NASDAQ:HQY) Investigated by Levi & Korsinsky, LLP

NEW YORK, NY / ACCESSWIRE / August 9, 2024 / HealthEquity, Inc. ("HealthEquity") has disclosed a data breach affecting the personal information of its customers. The breach compromised sensitive personal information entrusted to HealthEquity.

Levi & Korsinsky, LLP Investigates HealthEquity, Inc. (NASDAQ: HQY) in Connection with Recent Data B

NEW YORK, NY / ACCESSWIRE / August 8, 2024 / HealthEquity, Inc. ("HealthEquity") has disclosed a data breach affecting the personal information of its customers. The breach compromised sensitive personal information entrusted to HealthEquity.

ATA BREACH: HealthEquity, Inc. (NASDAQ: HQY) Investigated by Levi & Korsinsky, LLP

NEW YORK, NY / ACCESSWIRE / July 31, 2024 / HealthEquity, Inc. ("HealthEquity") has disclosed a data breach affecting the personal information of its customers. The breach compromised sensitive personal information entrusted to HealthEquity.

Levi & Korsinsky, LLP Investigates HealthEquity, Inc. (NASDAQ:HQY) in Connection with Recent Data B

NEWTOWN, Pa., July 30, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by HealthEquity, Inc. (“Health Equity”). Health Equity learned of suspicious activity on or about March 25, 2024. To join this case, go HERE .

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of HealthEquity, Inc. Customers Whose Personal Data May Have Been Compromised

OKLAHOMA CITY, July 30, 2024 (GLOBE NEWSWIRE) -- Murphy Law Firm is investigating claims on behalf of all individuals whose personal and confidential information was compromised in the data breach involving HealthEquity. On March 25, 2024, HealthEquity detected suspicious activity on its computer network, indicating a data breach.

HealthEquity Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims

HealthEquity is notifying 4.3 million people following a March data breach that affects their personal and protected health information.

HealthEquity data breach affects 4.3 million people

PITTSBURGH, July 29, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (“HealthEquity”) recently announced that it suffered from a data breach which impacted the personal information of approximately 4.3 million individuals.1 The information potentially impacted in the breach includes individuals' names, addresses, phone numbers, Social Security Numbers, employee IDs, employers, dependent information, and payment card information. 2

Lynch Carpenter Investigates Claims in HealthEquity Data Breach

OKLAHOMA CITY--(BUSINESS WIRE)-- #Cobra--Federman & Sherwood Investigates HealthEquity Inc. for Data Breach.

Federman & Sherwood Investigates HealthEquity Inc. for Data Breach

Atkore International Group

The AZEK Company

Comfort Systems USA

Fabrinet

Lantheus Holdings

Modine Manufacturing

Matador Resources

Onto Innovation

Rush Enterprises

Matador Resources and Onto Innovation are widely held stocks among well-regarded small-cap funds.

10 Stocks That Star Small-Cap Funds Love

HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.

3 Reasons Why You Should Hold HealthEquity (HQY) Stock Now

On Tuesday, health tech services provider HealthEquity disclosed in a filing with federal regulators that it had suffered a data breach, in which hackers stole the “protected health information” of some customers.

HealthEquity says data breach is an ‘isolated incident'

Here's Why You Should Retain HealthEquity (HQY) Stock for Now

HealthEquity (HQY) Gains 25.3% YTD: What's Driving the Rally?

HealthEquity Inc NASDAQ: HQY is one of the nation's largest providers of health savings accounts (HSA) and consumer-directed benefits (CDB) services. Its platform enables individuals to open, transfer, and conveniently manage HSAs and businesses to administer them seamlessly.

HealthEquity Stock: Leading Health Savings Account Investment

HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in all its segments, in the first quarter of fiscal 2025.

HealthEquity (HQY) Q1 Earnings Surpass Estimates, Margins Up

HealthEquity is breaking out to a multiyear high early Tuesday after posting better-than-expected earnings, helped by the Fed's higher-for-longer interest rate policy.

HealthEquity Breaks Out On Earnings Beat, Fed Tailwinds

HealthEquity, Inc. (NASDAQ:HQY ) Q1 2025 Earnings Conference Call June 3, 2024 4:30 PM ET Company Participants Richard Putnam - Investor Relations Jon Kessler - President & Chief Executive Officer James Lucania - Executive Vice President & Chief Financial Officer Steve Neeleman - Vice Chair and Founder Conference Call Participants Glen Santangelo - Jefferies Allen Lutz - Bank of America Greg Peters - Raymond James George Hill - Deutsche Bank Stan Berenshteyn - Wells Fargo Securities David Larsen - BTIG Stephanie Davis - Barclays Mark Marcon - Baird Jack Wallace - Guggenheim Constantine Davides - JMP Operator Good afternoon, and welcome to the HealthEquity First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode.

HealthEquity, Inc. (HQY) Q1 2025 Earnings Call Transcript

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HealthEquity (HQY) Reports Q1 Earnings: What Key Metrics Have to Say

HealthEquity (HQY) came out with quarterly earnings of $0.80 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.50 per share a year ago.

News for HealthEquity Stock (HQY)